Development of Stability Indicating Assay Method and Degradation Studies of Selected Drugs Targeting Cardiovascular and Kidney Disorders

dc.contributor.guideMehta Priti
dc.coverage.spatial
dc.creator.researcherPrajapati Pintu
dc.date.accessioned2022-06-28T05:08:54Z
dc.date.available2022-06-28T05:08:54Z
dc.date.awarded2021
dc.date.completed2021
dc.date.registered2013
dc.description.abstractStability testing of pharmaceutical products is important to assure their stability and efficacy throughout the shelf life. It is a mandatory requirement by various regulatory agencies across the globe. newlineIn the first part of the study, accelerated stability studies of Levosimendan (LEV) were performed as per ICH Q1A (R2) guideline. Under accelerated stability conditions (40°C/75%RH), two unknown degradation impurities were found at a level of 0.05-0.15% by the HPLC analysis. Further, these impurities synthesized in a larger quantity and isolated from the crude sample using preparative chromatography. The structure of isolated impurities were characterized using various spectrometric and spectrophotometric methods including LC-MS/MS, NMR (1H, 13C, COSY, HMBC, and HSQC) and FTIR. Based upon the results, the structure of impurities were proposed as (2Z)-2-cyano-2-(2-{4-[(4S)-4-methyl-6-oxo-1, 4, 5, 6-tetrahydropyridazin-3-yl] phenyl} hydrazinylidene) ethanamide (DP1) and (5S)-5-Methyl-6-phenyl-4,5-dihyropyridazin-3(2H)-one (DP2). The origin of the impurities was also postulated by proposing the plausible mechanism of formation. newlineIn second part of thesis, solid state degradation study was carried out on Mirabegron (MIR) in its various forms i.e. amorphous, crystalline and equal ratio of both forms. All were subjected to 25°C/65% RH, 40°C/75% RH, 50°C/90% RH and 60°C/0% RH conditions along with and without solid stressors with open and closed conditions for different time interval. Also, liquid state degradation was carried out under acidic conditions to understand the degradation behavior of drug. The samples were analyzed by using HPLC and their degradation profile were compared to understand degradation behavior of drug under in its different forms. The formed degradation products were characterized using LC-MS analysis. Two degradation products were isolated using conventional column chromatography having purity of more than 95%. The isolated DP1 converted to DP2 upon storage due to its thermolabile nature
dc.description.note
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extent
dc.identifier.urihttp://hdl.handle.net/10603/389121
dc.languageEnglish
dc.publisher.institutionInstitute of Pharmacy
dc.publisher.placeAhmedabad
dc.publisher.universityNirma University
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.titleDevelopment of Stability Indicating Assay Method and Degradation Studies of Selected Drugs Targeting Cardiovascular and Kidney Disorders
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 17
Loading...
Thumbnail Image
Name:
01_thesis_title page.pdf
Size:
56.58 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02 thesis certificate.pdf
Size:
97.71 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03 acknowledgement.pdf
Size:
141.69 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_abstract.pdf
Size:
10.55 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05 content.pdf
Size:
46.44 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: